Correlation between clinimetric approach and German US7 score in rheumatoid arthritis patients treated with tocilizumab: a pilot study
Terenzi, R.; Santoboni, G.; Bartoloni, E.; Alunno, A.; Luccioli, F.; Gerli, R.
Clinical and Experimental Rheumatology 33(3): 445
2015
ISSN/ISBN: 0392-856X PMID: 25937244 Document Number: 682983
Document emailed within 1 workday
Related Documents
Van Herwaarden, N.; Herfkens-Hol, S.; van der Maas, A.; van den Bemt, B.J.F.; van Vollenhoven, R.F.; Bijlsma, J.W.J.; den Broeder, A.A. 2014: Dose reduction of tocilizumab in rheumatoid arthritis patients with low disease activity Clinical and Experimental Rheumatology 32(3): 390-394Manfredi, A.; Sebastiani, M.; Cassone, G.; Colaci, M.; Sandri, G.; Ferri, C. 2018: Tocilizumab for the treatment of patients with rheumatoid arthritis and interstitial lung diseases: a case series Clinical and Experimental Rheumatology 36(2): 342
Sprekeler, R.; Lemmel, E.M.; Obert, H.J. 1990: Correlation of clinical and serological findings in patients with rheumatoid arthritis treated for one year with interferon-gamma Zeitschrift für Rheumatologie 49(1): 1-7
Juhl, P.; Thudium, C.S.; Gudmann, N.S.; Karsdal, M.A.; Bay-Jensen, A.-C.; Siebuhr, A.S. 2018: IL-6 receptor inhibition modulates type IIi collagen and C-reactive protein degradation in rheumatoid arthritis patients with an inadequate response to anti-tumour necrosis factor therapy: analysis of connective tissue turnover in the tocilizumab RADIATE study Clinical and Experimental Rheumatology 36(4): 568-574
Shen, H.; Xia, L.; Lu, J. 2013: Interleukin-4 in rheumatoid arthritis patients with interstitial lung disease: a pilot study Indian Journal of Medical Research 138(6): 919-921
Brandão, F.M.; Coelho, P.; Pinto, P.; Combe, B. 2010: Tocilizumab - a new step in rheumatoid arthritis treatment Acta Reumatologica Portuguesa 35(3): 302-312
Dawes, P.T.; Sheeran, T.P.; Fowler, P.D.; Shadforth, M.F. 1987: Improving the response to gold or D-penicillamine by addition of sulphasalazine. a pilot study in 25 patients with rheumatoid arthritis Clinical and Experimental Rheumatology 5(2): 151-153
Gossec, L.; Steinberg, G.; Rouanet, S.; Combe, B. 2015: Fatigue in rheumatoid arthritis: quantitative findings on the efficacy of tocilizumab and on factors associated with fatigue. the French multicentre prospective PEPS Study Clinical and Experimental Rheumatology 33(5): 664-670
Jiang, L.; Zhao, N.; Ni, L. 2002: Retrospective study of adverse events in patients with rheumatoid arthritis treated with second-line drugs Zhonghua Liu Xing Bing Xue Za Zhi 23(3): 213-217
Macovei, L.; Ancuţa, C.; Pomîrleanu, C.; Chirieac, R. 2012: Identification of bone mass and bone turnover in patients with rheumatoid arthritis treated with corticosteroids in order to elaborate an optimal therapeutic approach Revista Medico-Chirurgicala a Societatii de Medici Si Naturalisti Din Iasi 116(2): 470-476
Nasonov, E.L. 2010: New approaches to pharmacotherapy for rheumatoid arthritis: perspective for use of tocilizumab (monoclonal antibodies to interleukin-6 receptor) Terapevticheskii Arkhiv 82(5): 64-71
Michaels, R.M.; Chang, Z.L.; Beezhold, D.H. 1994: Phospholipase A2 activity in peripheral blood cells of rheumatoid arthritis patients treated with methotrexate: a preliminary study Clinical and Experimental Rheumatology 12(6): 643-647
Sreekanth, V.R.; Handa, R.; Wali, J.P.; Aggarwal, P.; Dwivedi, S.N. 2000: Doxycycline in the treatment of rheumatoid arthritis--a pilot study Journal of the Association of Physicians of India 48(8): 804-807
Palmer, D.G.; Moller, P.W.; Highton, T.C. 1972: Niflumic acid in rheumatoid arthritis: a pilot study New Zealand Medical Journal 75(481): 351-352
Yildirim, K.; Karatay, S.; Melikoglu, M.Alkan.; Gureser, G.; Ugur, M.; Senel, K. 2005: Associations between acute phase reactant levels and disease activity score (DAS28) in patients with rheumatoid arthritis Annals of Clinical and Laboratory Science 34(4): 423-426
Lassere, M.; McQueen, F.; Østergaard, M.; Conaghan, P.; Shnier, R.; Peterfy, C.; Klarlund, M.; Bird, P.; O'Connor, P.; Stewart, N.; Emery, P.; Genant, H.; Edmonds, J. 2003: OMERACT Rheumatoid Arthritis Magnetic Resonance Imaging Studies. Exercise 3: an international multicenter reliability study using the RA-MRI Score Journal of Rheumatology 30(6): 1366-1375
Chevallard, M.; Venegoni, C.; Scaramuzza, D.; Carrabba, M.; Colombo, B. 1988: Pilot study on the use of captopril in treatment of refractory rheumatoid arthritis Giornale di Clinica Medica 69(6-7): 443-445; 447
Kochevar, R.J.; Kaplan, R.M.; Weisman, M. 1997: Financial and career losses due to rheumatoid arthritis: a pilot study Journal of Rheumatology 24(8): 1527-1530
Brühlmann, P.; Stucki, G.; Michel, B.A. 1994: Evaluation of a German version of the physical dimensions of the Health Assessment Questionnaire in patients with rheumatoid arthritis Journal of Rheumatology 21(7): 1245-1249
Sadowska-Wróblewska, M.; Wróblewska-Graff, T.; Weryńska-Przybylska, J.; Rell-Bakalarska, M.; Kurdybacha, J. 1988: Isoprinosine in the early pre-erosive stage of rheumatoid arthritis: a pilot study Zeitschrift für Rheumatologie 47(2): 113-116